UNDERSTANDING THE IMPACT OF CYP2D6-MEDIATED VENLAFAXINE PHARMACOKINETICS ON TREATMENT OUTCOMES IN LATE-LIFE DEPRESSION

Men, *Xiaoyu, Taylor, Z. L., Marshe, V. S., Blumberger, D. M., Karp, J. F., Kennedy, J. L., Lenze, E. J., Iii, C. F. R., Stefan, C., Mulsant, B. H., Ramsey, L. B., & Müller, D. J. (2025). UNDERSTANDING THE IMPACT OF CYP2D6-MEDIATED VENLAFAXINE PHARMACOKINETICS ON TREATMENT OUTCOMES IN LATE-LIFE DEPRESSION. International Journal of Neuropsychopharmacology, 28(Supplement_1), i329–i330. https://doi.org/10.1093/ijnp/pyae059.589
Authors:
Xiaoyu Men
Zachary L. Taylor
Victoria S. Marshe
Daniel M. Blumberger
Jordan F. Karp
James L. Kennedy
Eric J. Lenze
Charles F. Reynolds
Cristiana Stefan
Benoit H. Mulsant
Laura B. Ramsey
Daniel J. Müller
Affiliated Authors:
Victoria S. Marshe
Columbia Affiliation:
Subjects:
Molecular Mechanisms of Depression Treatment Strategies (OpenAlex Topic)
Effects of Ketogenic Diet on Health (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1093/ijnp/pyae059.589
DOI:
10.1093/ijnp/pyae059.589
Journal:
International Journal of Neuropsychopharmacology
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: